» Articles » PMID: 11380430

Antibodies to Factor XII and Recurrent Fetal Loss in Patients with the Anti-phospholipid Syndrome

Overview
Journal Br J Haematol
Specialty Hematology
Date 2001 May 31
PMID 11380430
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Forty female patients with either primary anti-phospholipid syndrome (n = 26) or systemic lupus erythematosus (anti-phospholipid syndrome positive) (n = 14) were investigated for levels of factor XII, the presence of lupus anticoagulant and antibodies to cardiolipin, beta 2-glycoprotein I and factor XII. Twenty-one patients had a history of recurrent fetal loss (> 2, mean = 2.6). Lupus anticoagulant positivity showed a weak association with recurrent fetal loss (odds ratio = 1.1). While there was no association between the presence of antibodies to cardiolipin or beta 2-glycoprotein I with recurrent fetal loss, antibodies to factor XII showed a strong and statistically significant association (odds ratio = 5.4, P = 0.025).

Citing Articles

Anti-Factor XII Autoantibodies in Patients with Recurrent Pregnancy Loss Recognize the Second Epidermal Growth Factor-Like Domain.

Sato Y, Sugi T, Sakai R TH Open. 2019; 3(3):e263-e272.

PMID: 31489398 PMC: 6721864. DOI: 10.1055/s-0039-1695709.


Recurrent pregnancy loss and thrombophilia.

DUva M, Di Micco P, Strina I, De Placido G J Clin Med Res. 2012; 2(1):18-22.

PMID: 22457696 PMC: 3299170. DOI: 10.4021/jocmr2010.02.260w.


Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy.

DUva M, Di Micco P, Strina I, Ranieri A, Alviggi C, Mollo A Biologics. 2009; 2(4):897-902.

PMID: 19707467 PMC: 2727898. DOI: 10.2147/btt.s3852.


Antiphospholipid antibodies: paradigm in transition.

Horstman L, Jy W, Bidot C, Ahn Y, Kelley R, Zivadinov R J Neuroinflammation. 2009; 6:3.

PMID: 19154576 PMC: 2640381. DOI: 10.1186/1742-2094-6-3.


Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.

Bertolaccini M, Mepani K, Sanna G, Hughes G, Khamashta M Ann Rheum Dis. 2006; 66(4):533-6.

PMID: 17020907 PMC: 1856053. DOI: 10.1136/ard.2006.059022.